Actinium Pharmaceuticals, Inc (ATNM) Stock Price

1.51 ▲ +0.06 (+4.14%)
Open: 1.51 Vol: 431.82K Day's range: 1.48 - 1.5543 Dec 12, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATNM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.51▲ 1.51▲ 1.51▼ 1.44▲ 1.38▲
MA10 1.51▲ 1.51▼ 1.49▲ 1.43▲ 1.42▲
MA20 1.51▲ 1.48▲ 1.46▲ 1.40▲ 1.53▼
MA50 1.47▲ 1.44▲ 1.43▲ 1.43▲ 1.46▲
MA100 1.45▲ 1.43▲ 1.41▲ 1.54▼ 3.25▼
MA200 1.43▲ 1.39▲ 1.40▲ 1.51▲ 5.29▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ 0.001▲ 0.005▲ 0.015▲ -0.004▼
RSI 59.432▲ 64.847▲ 64.227▲ 59.207▲ 49.542▼
STOCH 66.667     45.623     70.700     53.067     26.144    
WILL %R -50.000     -31.818     -25.926     -17.420▲ -45.098    
CCI 45.752     37.365     62.663     202.784▲ -9.348    
Latest Filters Detected On ATNM
▲ PSAR&MOM $ATNM PSAR Switch Up + Momentum Set Alert
MA $ATNM Price Crossed Above MA(200) Set Alert
▲ GAP $ATNM Open Gap Up %3 Set Alert
▲ GAP $ATNM Open Gap Up %2 Set Alert
CDL $ATNM Doji Candlestick Pattern Detected Set Alert
Actinium Pharmaceuticals, Inc News
Actinium Pharmaceuticals stock rises after promising breast cancer therapy data
Friday, December 12, 2025 07:29 AM
Investing.com -- Actinium Pharmaceuticals Inc (NYSE:ATNM) stock rose 3.7% on Friday following the presentation of new preclinical data for its breast cancer therapy candidate ATNM-400 at the 2025 San ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) Advances ATNM-400 Targeting STEAP-1 Across Prostate, Breast, and Lung Cancer
Wednesday, December 10, 2025 02:10 AM
Prostate, lung, and breast cancer alone account for over $60 billion in annual drug spending, yet resistance to current therapies continues to create costly failures. Actinium Pharmaceuticals (NYSE ...
ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa
Monday, December 08, 2025 07:35 AM
B7-H3 overexpression is linked to tumor aggressiveness, immune evasion, and treatment resistance, making it an increasingly important target. By pairing this biology with its radiotherapy expertise, ...
ATNM historical stock data
date open high low close volume
12/12/25 1.51 1.5543 1.48 1.51 431,824
11/12/25 1.42 1.475 1.41 1.45 88,400
10/12/25 1.44 1.455 1.41 1.42 146,332
09/12/25 1.40 1.45 1.371 1.43 259,500
08/12/25 1.45 1.47 1.40 1.40 139,400
05/12/25 1.45 1.47 1.40 1.43 86,000
04/12/25 1.45 1.54 1.41 1.45 80,026
03/12/25 1.38 1.475 1.38 1.45 151,031
02/12/25 1.37 1.40 1.33 1.38 112,600
01/12/25 1.40 1.42 1.355 1.37 383,800
Quote Details
52wk Low:1.029
52wk High:2.41
Vol:431.82K
Avg Vol(3m):4.1M
1Y Chng:+29.06%
1M Chng:+5.59%
Add to Watch List
More Information
Index NYSE AMEX Composite
Market Cap. 45.23M